Elevance Health Inc. (ELV), while reporting weak fourth-quarter earnings below market estimates, on Thursday issued fiscal 2025 ...
Vulcan Value Partners stated the following regarding Elevance Health, Inc. (NYSE:ELV) in its Q4 2024 investor letter: “There were no material contributors to performance. There were two material ...